Sutter, 55, said he knew he did not want "to do anything that was 'Sons' related immediately (after it ended)," but he is still interested in the possible prequel, reported Aceshowbiz.
"It's something that we have talked about. It's something that we have interest in. We are interested. I think the timing of it really depends on what unfolds," he said about the prequel.
He added now he chose to focus on his new series for FX, "The Bastard Executioner".
Explaining why there seems to be little or no progress on the "Sons" prequel, he shared, "I knew I didn't want to do anything that was 'Sons' related immediately. I didn't want to come right off of that and do a prequel or anything like that.
"I wanted to give it a couple years to breathe before we came back to do it. So none of that has gone away. We'll see how the next couple years or at least the next year with ('The Bastard Executioner') unfolds and then we'll have to see.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
